Oculis Holding AG (OCS)
8.72
+0.16
(+1.87%)
USD |
NASDAQ |
Oct 06, 16:00
8.72
0.00 (0.00%)
After-Hours: 19:58
Oculis Total Assets (Quarterly) : 310.34M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 310.34M |
| March 31, 2026 | 303.64M |
| December 31, 2025 | 297.84M |
| September 30, 2025 | 210.94M |
| June 30, 2025 | 228.17M |
| March 31, 2025 | 230.77M |
| December 31, 2024 | 132.80M |
| September 30, 2024 | 148.90M |
| June 30, 2024 | 154.39M |
| March 31, 2024 | 109.60M |
| December 31, 2023 | 135.87M |
| Date | Value |
|---|---|
| September 30, 2023 | 140.95M |
| June 30, 2023 | 150.72M |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 128.47M |
| September 30, 2021 | 128.74M |
| June 30, 2021 | 128.98M |
| March 31, 2021 | 122.22M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Novartis AG | 122.03B |
| Roche Holding AG | -- |
| Addex Therapeutics Ltd. | 4.311M |
| Sandoz Group AG | -- |
| Galderma Group AG | -- |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 38.43M |
| Shareholders Equity (Quarterly) | 271.91M |
| Debt to Equity Ratio | 0.0116 |
| Current Ratio | 8.347 |
| Net Debt Paydown Yield | -0.04% |